Stanley-Laman Group’s STAAR Surgical STAA Stock Holding History

Stanley-Laman Group’s Portfolio STAA Stock Details STAA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-127,939	Closed	-$4.08M	–	270
2018 Q4	$4.08M	Buy	+127,939	New	+$4.99M	1.13%	27

Other funds holding STAA

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Defender Capital Charlotte, North Carolina $308M AUM 4.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Stanley-Laman Group's STAA Position: Q1 2019 in Review

Stanley-Laman Group sold out of STAAR Surgical (STAA) in Q1 2019, closing a stake of 127,939 shares — an estimated $4.08M sold.

Stanley-Laman Group first reported a position in STAA in Q4 2018 and held it in 1 quarter. The position peaked at $4.08M in Q4 2018. 185 funds tracked by Wall St. Rank hold STAA as of Q1 2019.

Stanley-Laman Group reported no remaining STAAR Surgical position as of Q1 2019 after selling out during the quarter.
Stanley-Laman Group sold 127,939 STAAR Surgical shares in Q1 2019, an estimated $4.08M.
Stanley-Laman Group first reported a position in STAAR Surgical in Q4 2018 and held it in 1 quarter.
Stanley-Laman Group's STAAR Surgical position peaked at $4.08M in Q4 2018.
185 funds tracked by Wall St. Rank held STAAR Surgical as of Q1 2019.

Based on Stanley-Laman Group's 13F filing for Q1 2019, filed 10 May 2019.